You are here

Article Text

Article menu
Download PDFPDF
Case report
Sodium zirconium cyclosilicate for hyperkalaemia
  1. Aafreen Shaikh1 and
  2. Claire Stark Toller2
  1. 1 Mountbatten Hampshire, Southampton, UK
  2. 2 Palliative Medicine, Mountbatten Hampshire and University Hospital Southampton NHS Foundation Trust, Southampton, UK
  1. Correspondence to Dr Claire Stark Toller; claire.starktoller{at}uhs.nhs.uk

Abstract

Hyperkalaemia is a life-threatening medical emergency. Treatment usually requires admission to hospital. This is often inappropriate or unacceptable for patients in a hospice setting. Until recently, there was no palatable and effective non-invasive treatment for hyperkalaemia in a hospice. We present a case where oral sodium zirconium cyclosilicate was given to a hospice inpatient, was well tolerated and may have contributed to two additional weeks of good quality of life.

  • Hospice care
  • Terminal care
  • Cancer

https://doi.org/10.1136/spcare-2023-004629

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors AS conducted the literature search. CST and AS jointly wrote the paper

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; internally peer reviewed.